Related references
Note: Only part of the references are listed.Nasal Administration and Plasma Pharmacokinetics of Parathyroid Hormone Peptide PTH 1-34 for the Treatment of Osteoporosis
Richard G. Pearson et al.
PHARMACEUTICS (2019)
In vitro and preclinical assessment of an intranasal spray formulation of parathyroid hormone PTH 1-34 for the treatment of osteoporosis
Allan J. Williams et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2018)
Effect of dosing frequency of teriparatide (PTH 1-34) on bone formation in rats: comparison of bone metabolism marker levels
Atsushi Watanabe et al.
JOURNAL OF TOXICOLOGICAL SCIENCES (2018)
Advanced formulations for intranasal delivery of biologics
Julia Rohrer et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2018)
Validation of an ultrasensitive LC-MS/MS method for PTH 1-34 in porcine plasma to support a solid dose PK study
Richard G. Kay et al.
BIOANALYSIS (2015)
Mechanism of Mucosal Permeability Enhancement of CriticalSorb® (Solutol® HS15) Investigated In Vitro in Cell Cultures
Saif Shubber et al.
PHARMACEUTICAL RESEARCH (2015)
Intranasal delivery of systemic-acting drugs: Small-molecules and biomacromolecules
Ana Fortuna et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2014)
An ultrasensitive method for the quantitation of active and inactive GLP-1 in human plasma via immunoaffinity LC-MS/MS
Derek L. Chappell et al.
BIOANALYSIS (2014)
Sequential Protein and Peptide Immunoaffinity Capture for Mass Spectrometry-Based Quantification of Total Human β-Nerve Growth Factor
Hendrik Neubert et al.
ANALYTICAL CHEMISTRY (2013)
CriticalSorb™: enabling systemic delivery of macromolecules via the nasal route
Andrew L. Lewis et al.
DRUG DELIVERY AND TRANSLATIONAL RESEARCH (2013)
Nasal drug delivery devices: characteristics and performance in a clinical perspective-a review
Per Gisle Djupesland
DRUG DELIVERY AND TRANSLATIONAL RESEARCH (2013)
CriticalSorb™: A novel efficient nasal delivery system for human growth hormone based on Solutol HS15
Lisbeth Illum et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Nasal drug delivery - Recent developments and future prospects
Lisbeth Illum
JOURNAL OF CONTROLLED RELEASE (2012)
A systematic review of hip fracture incidence and probability of fracture worldwide
J. A. Kanis et al.
OSTEOPOROSIS INTERNATIONAL (2012)
CriticalSorb™ Promotes Permeation of Flux Markers Across Isolated Rat Intestinal Mucosae and Caco-2 Monolayers
D. J. Brayden et al.
PHARMACEUTICAL RESEARCH (2012)
The influence of additives on the nanoscopic dynamics of the phospholipid dimyristoylphosphatidylcholine
Sebastian Busch et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2011)
Pharmacokinetics of Teriparatide (rhPTH[1-34]) and Calcium Pharmacodynamics in Postmenopausal Women with Osteoporosis
Julie Satterwhite et al.
CALCIFIED TISSUE INTERNATIONAL (2010)
Nasal and rectal delivery of insulin with chitosan and N-trimethyl chitosan chloride
Lissinda H. du Plessis et al.
DRUG DELIVERY (2010)
Intranasal Delivery to the Central Nervous System: Mechanisms and Experimental Considerations
Shyeilla V. Dhuria et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2010)
In vitro permeation of desmopressin across rabbit nasal mucosa from liquid nasal sprays: The enhancing effect of potassium sorbate
Bortolotti Fabrizio et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2009)
Novel dry powder inhaler formulation of glucagon with addition of citric acid for enhanced pulmonary delivery
Satomi Onoue et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2009)
Intranasal Drug Delivery: How, Why and What for?
Anaisa Pires et al.
JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES (2009)
Nasal Delivery of High Molecular Weight Drugs
Yildiz Ozsoy et al.
MOLECULES (2009)
Permeation studies of indomethacin from different emulsions for nasal delivery and their possible anti-inflammatory effects
H. Yesim Karasulu et al.
AAPS PHARMSCITECH (2008)
Effects of the antiepileptic drug carbamazepine on human erythrocytes
Mario Suwalsky et al.
TOXICOLOGY IN VITRO (2006)
Daily nasal spray of hPTH(1-34) for 3 months increases bone mass in osteoporotic subjects: a pilot study
T. Matsumoto et al.
OSTEOPOROSIS INTERNATIONAL (2006)
A review of teriparatide and its clinical efficacy in the treatment of osteoporosis
H Dobnig
EXPERT OPINION ON PHARMACOTHERAPY (2004)
Intranasal delivery of recombinant human parathyroid hormone [hPTH (1-34)], teriparatide in rats
RU Agu et al.
ENDOCRINE RESEARCH (2004)
Stability of desmopressin loaded in liposomes
SL Law et al.
JOURNAL OF LIPOSOME RESEARCH (2003)
Nasal drug delivery: new developments and strategies
L Illum
DRUG DISCOVERY TODAY (2002)
Analysis of transient and reversible effects of poly-L-arginine on the in vivo nasal absorption of FITC-dextran in rats
K Ohtake et al.
JOURNAL OF CONTROLLED RELEASE (2002)
Aminated gelatin as a nasal absorption enhancer for peptide drugs: evaluation of absorption enhancing effect and nasal mucosa perturbation in rats
J Wang et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2002)
Folding and stability of the three-stranded beta-sheet peptide betanova: Insights from molecular dynamics simulations
G Colombo et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2002)
Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis.
RM Neer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Share Paper
